Dr. Karen Mendoza Bravo made history this summer as the first woman surgeon to perform the Himplant procedure, a specialized cosmetic implant designed to enhance penile appearance. The milestone procedure took place in Puerto Vallarta, Mexico, where Mendoza now operates a practice offering consultations and surgical interventions for adult patients.
Mendoza is a urologist with extensive training in minimally invasive and robotic surgical techniques. Her clinical expertise spans endourology, laparoscopic approaches and complex reconstructive work, positioning her as a notable addition to the Himplant physician network, which operates across multiple continents.
The Himplant device is a medical-grade silicone implant inserted beneath the penile skin. The FDA cleared it for cosmetic use to increase girth while enhancing the appearance of flaccid length in screened adult male patients.
"Being the first woman surgeon to perform the Himplant procedure is an honor and an important professional milestone," Mendoza said in a statement. "My priority is to provide patients with careful evaluation, clear information and attentive care throughout the surgical and recovery process. I am proud to help expand access to this procedure in Mexico."
Puerto Vallarta has emerged as a destination for the procedure, reflecting a broader trend in medical tourism within Latin America. The coastal city offers geographic accessibility for patients traveling from Mexico, the United States and Canada, making it an attractive hub for specialized surgical services.
Women remain underrepresented in surgical specialties overall, and Mendoza's distinction as the first woman to perform this procedure highlights ongoing gender disparities in surgical practice. Her presence in the Himplant network may signal the field's gradual shift toward greater diversity among practicing surgeons.
The Himplant physician network has expanded significantly since FDA clearance, with participating surgeons and clinics operating in multiple U.S. states, across Latin America and in the Middle East. Like all surgeries, the procedure carries inherent risks that are disclosed to prospective patients. Candidacy is determined individually following comprehensive medical evaluation.
